Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
63 participants
OBSERVATIONAL
2017-02-01
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
NCT01317147
Pharmacokinetics and Pharmacodynamics of Oral Sertraline Before and After Bariatric Surgery
NCT04147000
Risk Factors of Depression, Anxiety and Eating Disorder After Bariatric Surgery
NCT06491069
Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery
NCT01214382
Psychological and Psychopathological Characteristics of Patients With Obesity Candidates for Bariatric Surgery
NCT06556459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bariatric surgery
consisting of gastric bypass surgery: Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG)
Roux-en-Y gastric bypass, sleeve gastrectomy
bariatric surgery with the goal loosing weight
conservative therapy
consisting of medical visits, nutritional counseling, physiotherapy, anti-obesogenic medication and psychological coaching
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Roux-en-Y gastric bypass, sleeve gastrectomy
bariatric surgery with the goal loosing weight
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \>35
* Existing antidepressant drug therapy with SSRI or SNRI
* Written informed consent
Exclusion Criteria
* Active drug addiction or psychosis
* Severe depression (BDI score \>30)
* Suicidality at the beginning of the study
* Gastrointestinal malabsorption
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Zürich
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER
Luzerner Kantonsspital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Pasi, MD
Role: PRINCIPAL_INVESTIGATOR
Universitätsspital Zürich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Luzerner Kantonsspital
Lucerne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021IJO00233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.